Search

Your search keyword '"Jenkins V"' showing total 563 results

Search Constraints

Start Over You searched for: Author "Jenkins V" Remove constraint Author: "Jenkins V"
563 results on '"Jenkins V"'

Search Results

1. The affect of goserelin on the QoL of women having chemotherapy for EBC: Results from the OPTION trial

4. Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study)

18. Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

21. A digital pathway for genetic testing in UK NHS cancer patients: BRCA-DIRECT randomised study internal pilot

22. Clinical and Metabolic Characterization of Adults With Type 2 Diabetes by Age in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) Cohort

24. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

26. 156TiP BRCA-DIRECT: A randomised UK study evaluating a digital pathway for germline genetic testing and non-inferiority of digitally-delivered information in women with breast cancer

29. POSNOC—POsitive Sentinel NOde : adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy : a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes

36. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

37. POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes

39. Patientsʼ preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

41. Clinical impact of the predict prostate risk communication tool in men newly diagnosed with non-metastatic prostate cancer: A multi-centre randomised controlled trial

Catalog

Books, media, physical & digital resources